BioMarin Pharmaceutical (BMRN): are the analysts right?

BioMarin Pharmaceutical · Health Care · ref. ETF XLV · 110 calls · price $57.68
What the company does: BioMarin Pharmaceutical développe des thérapies pour les maladies rares.
📈 1-year price
$60.35+4.1% over range
Jul 8, 25low $49.67 · high $64.08Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 14 analysts

🎯 Analyst price target on BMRN

High target · 2 analysts$120+108.0%
Median target · 14 analysts$85+47.4%
Low target · 1 analyst$50-13.3%
Current price$57.68

🗳️ The analyst consensus

Analyst breakdown · 14 (6 months)
Strong Buy0%
Buy86%
Hold14%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on BMRN

Most reliable analysts on BMRN (% profitable · 365j · ≥2 calls)
Canaccord Genuity 60% +5.2% 10
Jefferies 45% +6.9% 11
Stifel 33% -10.7% 12
Piper Sandler 25% -8.1% 12
Cantor Fitzgerald 0% -19.6% 12
Bernstein 0% -30.6% 2

📊 What $1,000 invested in BioMarin Pharmaceutical would be worth

In short — $1,000 invested in BioMarin Pharmaceutical 10 years ago would be worth $546 today, i.e. -6%/yr on average. Best year: 2022 (+17%), worst: 2024 (-32%). Price performance, excluding dividends.

If I'd invested $1,000 in BioMarin Pharmaceutical

InvestmentWorth todayGain
1 years ago$871-13%
3 years ago$553-45%
5 years ago$653-35%
10 years ago$546-45%
since inception (1999)$3,692+269%

Return by year (BioMarin Pharmaceutical)

YearReturn$1,000 invested at year start
2026 (YTD)-4%$963 (-4%)
2025-10%$871 (-13%)
2024-32%$593 (-41%)
2023-7%$553 (-45%)
2022+17%$648 (-35%)
2021+1%$653 (-35%)
2020+4%$677 (-32%)
2019-1%$672 (-33%)
2018-5%$642 (-36%)
2017+8%$691 (-31%)
2016-21%$546 (-45%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on BMRN

▲ Buy · 🎯$111
Price at call : $52.88 — upside +110%
Today : $57.68 — upside +92%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : May 22, 27
▲ Buy · 🎯$80
Price at call : $50.2 — upside +59%
Today : $57.68 — upside +39%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : May 19, 27
Citigroup
May 19, 26
▲ Buy · 🎯$75
Price at call : $50.2 — upside +49%
Today : $57.68 — upside +30%
🎯 on BMRN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 19, 27
■ Neutral neutral · not a buy · 🎯$50
Price at call : $49.81 — gap to target +0%
Today : $57.68 — gap to target -13%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : May 18, 27
▲ Buy · 🎯$116
Price at call : $54.06 — upside +115%
Today : $57.68 — upside +101%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : May 8, 27
Bernstein
May 5, 26
▲ Outperform · 🎯$82
Price at call : $54.6 — upside +50%
Today : $57.68 — upside +42%
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 60% · +5.1% (5 calls)
in progress (365j)
matures : May 5, 27
▲ Overweight · 🎯$119
Price at call : $54.6 — upside +118%
Today : $57.68 — upside +106%
🎯 on BMRN : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : May 5, 27
RBC Capital
May 5, 26
■ Sector Perform neutral · not a buy · 🎯$66
Price at call : $54.6 — gap to target +21%
Today : $57.68 — gap to target +14%
🎯 on BMRN : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : May 5, 27
▲ Outperform · 🎯$120
Price at call : $54.6 — upside +120%
Today : $57.68 — upside +108%
🎯 on BMRN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : May 5, 27
■ Neutral neutral · not a buy · 🎯$55
Price at call : $53.24 — gap to target +3%
Today : $57.68 — gap to target -5%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : May 5, 27
▲ Buy · 🎯$85
Price at call : $60.32 — upside +41%
Today : $57.68 — upside +47%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Mar 11, 27
Barclays
Mar 4, 26
▲ Overweight · 🎯$105
Price at call : $60.57 — upside +73%
Today : $57.68 — upside +82%
🎯 on BMRN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Mar 4, 27
■ Neutral neutral · not a buy · 🎯$55
Price at call : $59.74 — gap to target -8%
Today : $57.68 — gap to target -5%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Mar 2, 27
▲ Buy · 🎯$105
Price at call : $59.74 — upside +76%
Today : $57.68 — upside +82%
🎯 on BMRN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Mar 2, 27
▲ Buy · 🎯$104
Price at call : $61.73 — upside +68%
Today : $57.68 — upside +80%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Feb 26, 27
Bernstein
Feb 25, 26
▲ Outperform · 🎯$94
Price at call : $61.11 — upside +54%
Today : $57.68 — upside +63%
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 60% · +5.1% (5 calls)
in progress (365j)
matures : Feb 25, 27
Guggenheim
Feb 25, 26
▲ Buy · 🎯$86
Price at call : $61.44 — upside +40%
Today : $57.68 — upside +49%
🎯 on BMRN : no call matured yet · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Feb 25, 27
■ Neutral neutral · not a buy · 🎯$55
Price at call : $61.44 — gap to target -10%
Today : $57.68 — gap to target -5%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 25, 27
Oppenheimer
Feb 24, 26
▲ Outperform · 🎯$95
Price at call : $62.62 — upside +52%
Today : $57.68 — upside +65%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 52.9% · +4.5% (68 calls)
in progress (365j)
matures : Feb 24, 27
Wells Fargo
Feb 18, 26
▲ Overweight · 🎯$75
Price at call : $61.83 — upside +21%
Today : $57.68 — upside +30%
🎯 on BMRN : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 18, 27
▲ Overweight · 🎯$84
Price at call : $57.81 — upside +45%
Today : $57.68 — upside +46%
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Feb 6, 27
▲ Buy · 🎯$98
Price at call : $56.31 — upside +74%
Today : $57.68 — upside +70%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Jan 20, 27
▲ Buy · 🎯$100
Price at call : $61.14 — upside +64%
Today : $57.68 — upside +73%
🎯 on BMRN : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Dec 23, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $59.28 — gap to target +1%
Today : $57.68 — gap to target +4%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Dec 22, 26
■ Market Perform neutral · not a buy · 🎯$60
Price at call : $54.31 — gap to target +10%
Today : $57.68 — gap to target +4%
🎯 on BMRN : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Dec 3, 26
Stifel
Nov 6, 25
■ Hold neutral · not a buy · 🎯$61
Price at call : $51.84 — gap to target +18%
Today : $57.68 — gap to target +6%
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Nov 6, 26
▲ Buy · 🎯$100
Price at call : $52.52 — upside +90%
Today : $57.68 — upside +73%
🎯 on BMRN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 3, 26
Bernstein
Nov 3, 25
▲ Outperform · 🎯$88
Price at call : $52.85 — upside +67%
Today : $57.68 — upside +53%
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 60% · +5.1% (5 calls)
in progress (365j)
matures : Nov 3, 26
▲ Buy · 🎯$80
Price at call : $51.86 — upside +54%
Today : $57.68 — upside +39%
🎯 on BMRN : no call matured yet · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Oct 28, 26
Wells Fargo
Oct 28, 25
▲ Overweight · 🎯$70
Price at call : $51.86 — upside +35%
Today : $57.68 — upside +21%
🎯 on BMRN : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Oct 28, 26
Stifel
Oct 28, 25
▲ Buy · 🎯$73
Price at call : $51.86 — upside +41%
Today : $57.68 — upside +27%
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Oct 28, 26
Barclays
Oct 28, 25
▲ Overweight · 🎯$80
Price at call : $53.49 — upside +50%
Today : $57.68 — upside +39%
🎯 on BMRN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 28, 26
▲ Overweight · 🎯$98
Price at call : $53.49 — upside +83%
Today : $57.68 — upside +70%
🎯 on BMRN : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Oct 28, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $52.67 — gap to target +4%
Today : $57.68 — gap to target -5%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Oct 27, 26
JP Morgan
Oct 9, 25
▲ Overweight · 🎯$119
Price at call : $53.85 — upside +121%
Today : $57.68 — upside +106%
🎯 on BMRN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Oct 9, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $56.38 — gap to target +6%
Today : $57.68 — gap to target +4%
🎯 on BMRN : no call matured yet · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 8, 26
Guggenheim
Aug 6, 25
▲ Buy · 🎯$106
Price at call : $59.46 — upside +78%
Today : $57.68 — upside +84%
🎯 on BMRN : no call matured yet · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Aug 6, 26
UBS
Aug 5, 25
▲ Buy · 🎯$114
Price at call : $61.93 — upside +84%
Today : $57.68 — upside +98%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Aug 5, 26
▲ Overweight · 🎯$96
Price at call : $59.2 — upside +62%
Today : $57.68 — upside +66%
🎯 on BMRN : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jul 22, 26
JP Morgan
Jul 14, 25
▲ Overweight · 🎯$113
Price at call : $56.62 — upside +100%
Today : $57.68 — upside +96%
🎯 on BMRN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jul 14, 26
▲ Buy · 🎯$104
Price at call : $59.64 — upside +74%
Today : $57.68 — upside +80%
Expected +74% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 52.2% · +7.8% (90 calls)
-8.5%
stock -8% · XLV +8%
Citigroup
May 2, 25
■ Neutral neutral · not a buy · 🎯$78
Price at call : $62.06 — gap to target +26%
Today : $57.68 — gap to target +35%
🎯 on BMRN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 2, 26
Oppenheimer
Feb 24, 25
▲ Outperform · 🎯$98
Price at call : $69.01 — upside +42%
Today : $57.68 — upside +70%
Expected +42% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 52.9% · +4.5% (68 calls)
-9.3%
stock -9% · XLV +7%
Scotiabank
Feb 20, 25
■ Sector Perform neutral · not a buy · 🎯$80
Price at call : $68.25 — gap to target +17%
Today : $57.68 — gap to target +39%
🎯 on BMRN : no call matured yet · 📊 on Health : 0% · -10.9% (4 calls)
in progress (365j)
matures : Feb 20, 26
Citigroup
Feb 20, 25
■ Neutral neutral · not a buy · 🎯$82
Price at call : $68.25 — gap to target +20%
Today : $57.68 — gap to target +42%
🎯 on BMRN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Feb 20, 26
RBC Capital
Feb 20, 25
■ Sector Perform neutral · not a buy · 🎯$70
Price at call : $68.25 — gap to target +3%
Today : $57.68 — gap to target +21%
🎯 on BMRN : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 20, 26
▲ Overweight · 🎯$90
Price at call : $68.25 — upside +32%
Today : $57.68 — upside +56%
Expected +32% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
-7.8%
stock -8% · XLV +8%
UBS
Feb 20, 25
▲ Buy · 🎯$113
Price at call : $68.25 — upside +66%
Today : $57.68 — upside +96%
Expected +66% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
-7.8%
stock -8% · XLV +8%
Piper Sandler
Feb 20, 25
▲ Overweight · 🎯$126
Price at call : $68.73 — upside +83%
Today : $57.68 — upside +118%
Expected +83% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
-6.8%
stock -7% · XLV +7%
▲ Buy · 🎯$103
Price at call : $68.73 — upside +50%
Today : $57.68 — upside +79%
Expected +50% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
-6.8%
stock -7% · XLV +7%
▲ Overweight · 🎯$90
Price at call : $66.01 — upside +36%
Today : $57.68 — upside +56%
Expected +36% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
-21.0%
stock -21% · XLV +11%
▲ Outperform · 🎯$95
Price at call : $63.42 — upside +50%
Today : $57.68 — upside +65%
Expected +50% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 46.2% · +2.9% (13 calls)
-14.1%
stock -14% · XLV +7%
▲ Overweight · 🎯$90
Price at call : $65.89 — upside +37%
Today : $57.68 — upside +56%
Expected +37% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
-18.7%
stock -19% · XLV -2%
William Blair
Oct 30, 24
■ Market Perform neutral · not a buy
🎯 on BMRN : no call matured yet · 📊 on Health : 47.4% · +30.6% (19 calls)
in progress (365j)
matures : Oct 30, 25
Stifel
Sep 17, 24
▲ Buy · 🎯$87
Price at call : $70.55 — upside +23%
Today : $57.68 — upside +51%
Expected +23% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
-22.9%
stock -23% · XLV -12%
Bernstein
Sep 17, 24
▲ Outperform · 🎯$90
Price at call : $70.55 — upside +28%
Today : $57.68 — upside +56%
Expected +28% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 60% · +5.1% (5 calls)
-22.9%
stock -23% · XLV -12%
▲ Overweight · 🎯$110
Price at call : $84.85 — upside +30%
Today : $57.68 — upside +91%
Expected +30% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
-35.8%
stock -36% · XLV -12%
▲ Overweight · 🎯$122
Price at call : $84.08 — upside +45%
Today : $57.68 — upside +112%
Expected +45% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
-32.9%
stock -33% · XLV -10%
Piper Sandler
Aug 27, 24
▲ Overweight · 🎯$107
Price at call : $90.32 — upside +18%
Today : $57.68 — upside +86%
Expected +18% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
-36.1%
stock -36% · XLV -12%
Stifel
Aug 21, 24
▲ Buy · 🎯$115
Price at call : $90.02 — upside +28%
Today : $57.68 — upside +99%
Expected +28% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
-34.9%
stock -35% · XLV -11%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)